ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$RVMD:NASDAQ · REVOLUTION MEDICINES INC

Sector: health

Conviction from: NASDAQCitrini

52-week range: 67.86224.31

Revolution Medicines is a clinical-stage oncology company developing targeted therapies against RAS and related cancer-driving mutations.

5 tracked filer(s) hold this · 0 opened, 4 added, 0 trimmed in 30-SEP-2026

Aggregate 13FScore 64 — mean of 5 scored holder(s) · buyers (new/add) avg 70. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Stanley Druckenmiller / Duquesne91Added +9%436,287$89,5522.0%
Louis Bacon / Moore52Added +4%85,180$17,484,0470.3%
Steve Cohen / Point7275Added +184%228,971$46,998,5870.1%
Paul Tudor Jones / Tudor61Added +8%47,900$9,831,9540.0%
Ancora42Holds (flat)20$4,1050.0%

Beyond 13F — activists, insiders, politicians & research

Trump & executive branch trades all Trump/exec trades →

4 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-09-22Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-08-22Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-07-01Trump, Donald J PresidentSELL$50,001 - $100,000PTR
2026-05-14Trump, Donald J PresidentBUY$1,001 - $15,000PTR

Citrini Research coverage report library →

ReportDateStance
#124 — State of the Themes: June 20262026-06-01LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.